Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
Clinical trial NCT05185505 · RECRUITING
Trial details
- NCT number
- NCT05185505
- Sponsor
- The Methodist Hospital Research Institute
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2027-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.